Clinical Trials
3 trialsNCT05705492 2026-01-21
Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer
OHSU Knight Cancer Institute
Phase 2 Recruiting
NCT06517199 2024-07-24
Olanzapine for Cancer Related Anorexia-cachexia Syndrome
Mahidol University
Phase 3 Recruiting
NCT00489593 2015-01-08
Olanzapine in Patients With Advanced Cancer and Weight Loss
M.D. Anderson Cancer Center
Phase 1 Completed